FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medical pharmacology. Pharmaceutical composition with antibacterial activity includes fluoroquinolone, cyclodextrin and hydrochloric acid, and molar ratio of fluoroquinolone to cyclodextrin consists 1:0.5-2.0, composition additionally contains buffer component with the following component ratio, wt %: fluoroquinolone 0.5-10.0; cyclodextrin 3.0-45.0; hydrochloric acid 0.0005-1.0; buffer component 0.1-2.0; water to 100.0.
EFFECT: invention insures high composition stability.
6 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AND METHOD FOR PULMONARY ADMINISTRATION THEREOF | 2010 |
|
RU2445119C2 |
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FARM ANIMALS AND POULTRY | 2015 |
|
RU2570389C1 |
MEDICINAL AGENT FOR TREATMENT OF SUPPURATIVE-INFLAMMATORY SKIN AND SOFT TISSUE DISEASES OF DIFFERENT AETIOLOGY | 2006 |
|
RU2326667C1 |
LOCAL ANTIMICROBIAL AGENT | 2007 |
|
RU2336877C1 |
PURIFIED DERIVATIVES OF SULFOALKYL ETHERS OF CYCLODEXTRINE OR THEIR MIXTURE, CLATRATE COMPLEX OF CYCLODEXTRINE DERIVATIVES WITH MEDICINAL, AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2113442C1 |
Authors
Dates
2011-12-10—Published
2010-07-20—Filed